Paul Johnson

Paul Johnson

Baker & McKenzie CVBA/SCRL


Paul Johnson is a partner in Baker McKenzie Brussels' European & Competition Law Practice. He is an English qualified solicitor and has been practicing in Brussels and the UK for almost 15 years. Paul regularly represents clients on competition matters before the European Commission and has provided competition law advice with respect to over 100 jurisdictions around the world.

Practice Focus

Paul has extensive experience in all areas of EU competition law, including multijurisdictional and EU merger control (notifications and third party complaints), joint ventures, cartels, abuse of dominance, distribution and other commercial relationships.

Representative Legal Matters

  • Represented Hitachi in relation to its proposed USD 11 billion acquisition of ABB power grid business.
  • Represented a global technology firm on merger control filings on a variety of matters.
  • Represented a global pharmaceutical company on merger control filings and compliance with Article 101 on a variety of matters.
  • Represented Abbott Laboratories on its USD 5.8 billion acquisition of Alere, Inc.
  • Represented Lundbeck on global merger control filings with respect to its acquisition of Alder BioPharmaceuticals for USD 1.95 billion and Abide Therapeutics for USD 250 million.
  • Represented Jin Jiang on global merger control filings with respect to its USD 1.3 billion acquisition of Radisson.
  • Represented Warner Bros. on the European Commission’s investigation into cross-border access to pay-TV content (case AT.40023), and successfully negotiated a settlement agreement with the case team.
  • Represented a payment scheme on a variety of regulatory issues including dealing with National Banks and EU regulations in the payment sector including the Anti-Money laundering directive, PSDII, the Interchange fee Regulation and the ECB’s proposal on cyber resilience.
  • Represented a major global financial institution with respect to a number of investigations concerning potentially collusive behaviour.
  • Represented a major global insurance institution on Brexit, and developed options to ensure continued access to the EU single market.
  • Represented a major insurance company on the London Market dry run that tested the resilience of the world’s pre-eminent insurance market to a major loss event.
  • Represented a major European financial trade association to oppose the proposed USD9.53 billion acquisition of NYSE Euronext by Deutsche Börse blocked by the European Commission.
  • Represented a major scientific instrument company in relation to its proposed USD1.5 billion merger, and successfully negotiated an upfront remedy with the European Commission to obtain extended phase I clearance. 


  • Brussels [E-List]~Belgium (2007)
  • England & Wales~United Kingdom (2006)


  • King's College London, UK (Post Graduate Diploma Economics & Law) (2008)
  • King's College London, UK (Post Graduate Diploma Competition Law) (2007)
  • University of Edinburgh (LL.B. Hons) (2001)


  • English
  • Author, “The Stories Merger Documents Tell – the US, EU and Asian Perspectives” (ECLR 2018, 39, Issue 4). This article won Concurrence 2019 Award for Academic Articles.
  • Author, “The Rediscovery of Vertical Merger Enforcement?” CPI Antitrust Chronicle, Vol. 2, pp. 39 et seq., Competition Policy International, Inc. (August 2018).
  • Author, “A warning shot across the bows of global competition law compliance programmes: Antitrust scrutiny of joint bidding arrangements around the world,” 39 ECLR, Issue 10 (2018).
  • Author, “Brexit: The implications for EU and UK merger control,” Competition Law Journal, Jordans Publishing (18 July 2016).